Cardinal Health: Recall Of 267 Million Monoject Syringes May ‘Contribute To Market Disruption’

The recall of such a massive number of syringes could cause supply problems

A logo sign outside of the headquarters of Cardinal Health, Inc., in Dublin, Ohio
(Alamy Stock Photo)

More from Recalls

More from Policy & Regulation